Low lymphocyte count and cardiovascular diseases

Current Medicinal Chemistry

Volumn 18, Issue 21, 2011, Pages 3226-3233

  Nunez J ^a   Minana G ^a   Bodi V ^a   Nunez E ^a   Sanchis, J ^a   Husser, O ^b   Llacer A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Cardiovascular disease; Immunodeficiency; Inflammation; Low lymphocyte count; Lymphocyte apoptosis; Risk stratification

Indexed keywords

CATECHOLAMINE; HYDROCORTISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; GRAFT RECIPIENT; HEART FAILURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; ISCHEMIC HEART DISEASE; LYMPHOCYTE; LYMPHOCYTE COUNT; PATHOPHYSIOLOGY; PROGNOSIS; RADIATION EXPOSURE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; LYMPHOCYTE COUNT; LYMPHOCYTES; LYMPHOPENIA; PROGNOSIS;

EID: 79959987174     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796391633     Document Type: Review

References (79)

1. Lloyd-Jones, D.; Adams, R. J.; Brown, T. M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T. B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P. M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M. M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V. L.; Rosamond, W.; Sacco, R.; Sorlie, P.; Roger, V. L.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N. D.; Wylie-Rosett, J.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation, 2010, 121, e46-e215.
2. Bodi, V.; Sanchis, J.; Nunez, J.; Mainar, L.; Minana, G.; Benet, I.; Solano, C.; Chorro, FJ.; Llacer, A: Uncontrolled immune response in acute myocardial infarction: unraveling the thread. Am. Heart. J., 2008, 156, 1065-73.
3. Seizer, P.; Gawaz, M.; May, A. E: Platelet-monocyte interactions-a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr. Med. Chem., 2008, 15, 1976-80.
4. Nunez, J.; Nunez, E.; Sanchis, J.; Bodi, V.; Llacer, A: Prognostic value of leukocytosis in acute coronary syndromes: the cinderella of the inflammatory markers. Curr. Med. Chem., 2006, 13, 2113-8. (Pubitemid 44132603)
5. Le Tulzo, Y.; Pangault, C.; Gacouin, A.; Guilloux, V.; Tribut, O.; Amiot, L.; Tattevin, P.; Thomas, R.; Fauchet, R.; Drénou, B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock, 2002, 18, 487-94.
6. Nunez, J. E.; Nunez, E.; Bertomeu, V.; Fácila, L.; Sanchis, J.; Bodí, V.; Sanjuán, R.; Blasco, M. L.; Martínez, A.; Llácer, A: Prognostic value of baseline white blood cell count in patients with acute myocardial infarction and ST segment elevation. Heart, 2005, 91, 1094-1095. (Pubitemid 41060027)
7. Núñez, J.; Fácila, L.; Llàcer, A.; Sanchís, J.; Bodí, V.; Bertomeu, V.; Sanjuán, R.; Blasco, M. L.; Consuegra, L.; Bosch, M. J.; Chorro, F. J: Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality. Rev. Esp. Cardiol., 2005, 58, 631-9. (Pubitemid 41065263)
8. Núñez, J.; Núñez, E.; Bodí, V.; Sanchis, J.; Miñana, G.; Mainar, L.; Santas, E.; Merlos, P.; Rumiz, E.; Darmofal, H.; Heatta, A. M.; Llàcer, A: Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am. J. Cardiol., 2008, 101, 747-52.
9. Major, A. S.; Fazio, S.; Linton, M. F: B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 1892-8. (Pubitemid 35315778)
10. Gupta, S.; Agrawal, A.; Agrawal, S.; Su, H.; Gollapudi, S: A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun. Ageing., 2006, 3, 5.
11. Kaplan, R. C.; Kingsley, L. A.; Gange, S. J.; Benning, L.; Jacobson, L. P.; Lazar, J.; Anastos, K.; Tien, P. C.; Sharrett, A. R.; Hodis, H. N: Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS, 2008, 22, 1615-24.
12. Ducloux, D.; Challier, B.; Saas, P.; Tiberghien, P.; Chalopin, J. M: CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J. Am. Soc. Nephrol., 2003, 14, 767-72. (Pubitemid 36246022)
13. Kusunoki, Y.; Kyoizumi, S.; Yamaoka, M.; Kasagi, F.; Kodama, K.; Seyama, T: Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction. Radiat. Res., 1999, 152, 539-543. (Pubitemid 29514157)
14. Huang, Y. L.; Chung, H. T.; Chang, C. J.; Yeh, K. W.; Chen, L. C.; Huang, J. L: Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis. Rheum., 2009, 60, 3766-75.
15. Thomson, S. P.; Gibbons, R. J.; Smars, P. A.; Suman, V. J.; Pierre, R. V.; Santrach, P. J.; Jiang, N. S: Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann. Intern. Med., 1995, 122, 335-41.
16. Blum, A.; Sclarovsky, S.; Rehavia, E.; Shohat, B: Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am. Heart. J., 1994, 127, 1226-1230. (Pubitemid 24176012)
17. Ommen, S. R.; Gibbons, R. J.; Hodge, D. O.; Thomson, S. P: Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am. J. Cardiol., 1997, 79, 812-814. (Pubitemid 27152347)
18. Zouridakis, E. G.; Garcia-Moll, X.; Kaski, J. C: Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am. J. Cardiol., 2000, 86, 449-51. (Pubitemid 30628614)
19. Tamhane, U. U.; Aneja, S.; Montgomery, D.; Rogers, E. K.; Eagle, K. A.; Gurm, H. S: Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am. J. Cardiol., 2008, 102, 653-7.
20. Dragu, R.; Huri, S.; Zuckerman, R. M.; Suleiman, M.; Mutlak, D.; Agmon, Y.; Kapeliovich, M.; Beyar, R.; Markiewicz, W.; Hammerman, H.; Aronson, D: Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis, 2008, 196, 405-12.
21. Núñez, J.; Sanchis, J.; Bodí, V.; Núñez, E.; Heatta, A. M.; Miñana, G.; Merlos, P.; Rumiz, E.; Palau, P.; Sanjuán, R.; Blasco, M. L.; Llàcer A: Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes. Eur. J. Intern. Med., 2009, 20, 768-74.
22. Núñez, J.; Núñez, E.; Bodí, V.; Sanchis, J.; Mainar, L.; Miñana, G.; Fácila, L.; Bertomeu, V.; Merlos, P.; Darmofal, H.; Palau, P.; Llàcer, A: Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coronary Artery Disease, 2010, 21, 1-7.
23. Levy, W. C.; Mozaffarian, D.; Linker, D. T.; Sutradhar, S. C.; Anker, S. D.; Cropp, A. B.; Anand, I.; Maggioni, A.; Burton, P.; Sullivan, M. D.; Pitt, B.; Poole-Wilson, P. A.; Mann, D. L.; Packer, M: The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation, 2006, 113, 1424-33. (Pubitemid 43739439)
24. Onsrud, M: Influence of in vivo hydrocortisone on some human blood leucocyte subpopulations. II. Effects on T cell-monocyte cooperation. Acta. Pathol. Microbiol. Scand.[C], 1981, 89, 321-7. (Pubitemid 12231460)
25. Ulich, T. R.; del Castillo, J.; Ni, R. X.; Bikhazi, N.; Calvin, L: Mechanisms of tumor necrosis factor alpha-induced lymphopenia, neutropenia, and biphasic neutrophilia: a study of lymphocyte recirculation and hematologic interactions of TNF alpha with endogenous mediators of leukocyte trafficking. J. Leukoc. Biol., 1989, 45, 155-67. (Pubitemid 19077302)
26. Thomson, S. P.; McMahon, L. J.; Nugent, C. A: Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin. Immunol. Immunopathol., 1980, 17, 506-514. (Pubitemid 11238564)
27. Cioca, D. P.; Watanabe, N.; Isobe, M: Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn. Heart J., 2000, 41, 385-98. (Pubitemid 30636379)
28. Westermann, J.; Bode, U: Distribution of activated T cells migrating through the body: a matter of life and death. Immunol. Today, 1999, 20, 302-6. (Pubitemid 29331534)
29. Agnoletti, L.; Curello, S.; Malacarne, F.; AirÃ, P.; Cargnonia, A.; Valgimiglid, M.; Ferrari, R: Immune activation in severe heart failure. Does etiology play a role? Eur. Heart J., 2004, 6(Suppl. F), F22-9. (Pubitemid 39505055)
30. Pasqui, A. L.; Di Renzo, M.; Bova, G.; Bruni, F.; Puccetti, L.; Pompella, G.; Auteri, A: T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clin. Exp. Med., 2003, 3, 37-44. (Pubitemid 36649012)
31. Krammer, P. H: CD95's deadly mission in the immune system. Nature, 2000, 407, 789-795.
32. Stoneman, V. E.; Bennett, M. R: Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond.), 2004, 107, 343-54. (Pubitemid 39389301)
33. Hawkins, C. A.; Collignon, P.; Adams, D. N.; Bowden, F. J.; Cook, M. C: Profound lymphopenia and bacteraemia. Intern. Med. J., 2006, 36, 385-8. (Pubitemid 43780701)
34. Caliguri, G.; Nicoletti, A: Lymphocytes responses in acute coronary syndromes: lack of regulation spawns deviant behaviour. Eur. Heart J., 2006, 27, 2485-6. (Pubitemid 44627282)
35. Goronzy, J. J.; Weyand, C. M: Immunosuppression in atherosclerosis. Circulation, 2006, 114, 1901-4.
36. Cheng, X.; Liao, Y. H.; Ge, H.; Li, B.; Zhang, J.; Yuan, J.; Wang, M.; Liu, Y.; Guo, Z.; Chen, J.; Zhang, J.; Zhang, L: TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J. Clin. Immunol., 2005, 25, 246-53. (Pubitemid 40884051)
37. Anker, S. D.; Egerer, K. R.; Volk, H. D.; Kox, W. J.; Poole-Wilson, P. A.; Coats, A. J: Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol., 1997, 79, 1426-30.
38. Niebauer, J.; Volk, H. D.; Kemp, M.; Dominguez, M.; Schumann, R. R.; Rauchhaus, M.; Poole-Wilson, P. A.; Coats, A. J.; Anker, S. D: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet, 1999, 353, 1838-1842. (Pubitemid 29251016)
39. Helfand, M.; Buckley, D. I.; Freeman, M.; Fu, R.; Rogers, K.; Fleming, C.; Humphrey, L. L: Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U. S. Preventive Services Task Force. Ann. Intern. Med., 2009, 151, 496-507.
40. Margolis, K. L.; Manson, J. E.; Greenland, P.; Rodabough, R. J.; Bray, P. F.; Safford, M.; Grimm, R. H. Jr.; Howard, B. V.; Assaf, A. R.; Prentice, R: Women's Health Initiative Research Group. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch. Intern. Med., 2005, 165, 500-8. (Pubitemid 40344380)
41. Madjid, M.; Awan, I.; Willerson, J. T.; Casscells, S. W: Leukocyte count and coronary heart disease implications for risk assessment. J. Am. Coll. Cardiol., 2004, 44, 1945-56. (Pubitemid 39473277)
42. Danesh, J.; Collins, R.; Appleby, P.; Peto, R: Association of fibrinogen, creactive protein, albumin, or leukocyte count with coronary heart disease. JAMA, 1998, 279, 1477.
43. Folsom, A. R.; Wu, K. K.; Rosamond, W. D.; Sharrett, A. R.; Chambless, L. E: Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 1997, 96, 1102.
44. Sweetnam, P. M.; Thomas, H. F.; Yarnell, J. W. G: Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am. J. Epidemiol., 1997, 145, 416-21. (Pubitemid 27084213)
45. Gillum, R. F.; Mussolino, M. E.; Madans, J. H: Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: The NHANES-I Epidemiologic Follow-up Study. Ann. Epidemiol., 2005, 15, 266-71. (Pubitemid 40386500)
46. Wheeler, J. G.; Mussolino, M. E.; Gillum, R. F.; Danesh, J: Associations between differential leucocyte count and incident coronary heart disease. Eur. Heart. J., 2004, 25, 1287-92.
47. Rana, J. S.; Boekholdt, S. M.; Ridker, P. M.; Jukema, J. W.; Luben, R.; Bingham, S. A.; Day, N. E.; Wareham, N. J.; Kastelein, J. J.; Khaw, K. T: Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J. Intern. Med., 2007, 262, 678-89. (Pubitemid 350135192)
48. Krishnaswamy, G.; Chi, D. S.; Kelley, J. L.; Sarubbi, F.; Smith, J. K.; Peiris, A: The cardiovascular and metabolic complications of HIV infection. Cardiol. Rev., 2000, 8, 260-268.
49. Maggi, P.; Serio, G.; Epifani, G.; Fiorentino, G.; Saracino, A.; Fico, C.; Perilli, F.; Lillo, A.; Ferraro, S.; Gargiulo, M.; Chirianni, A.; Angarano, G.; Regina, G.; Pastore, G: Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS, 2000, 14, 123-128.
50. Depairon, M.; Chessex, S.; Sudre, P.; Rodondi, N.; Doser, N.; Chave, J. P.; Riesen, W.; Nicod, P.; Darioli, R.; Telenti, A.; Mooser, V.; Swiss HIV Cohort Study: Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy. AIDS, 2001, 15, 329-334. (Pubitemid 32163818)
51. Constans, J.; Marchand, J. M.; Conri, C.; Peuchant, E.; Seigneur, M.; Rispal, P.; Lasseur, C.; Pellegrin, J. L.; Leng, B: Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study. Ann. Med., 1995, 27, 683-685. (Pubitemid 26003734)
52. Hsue, P. Y.; Lo, J. C.; Franklin, A.; Bolger, A. F.; Martin, J. N.; Deeks, S. G.; Waters, D. D: Progression of atherosclerosis as assessed by carotid intimamedia thickness in patients with HIV infection. Circulation, 2004, 109, 1603-8. (Pubitemid 38451715)
53. Periard, D.; Cavassini, M.; Taffé, P.; Chevalley, M.; Senn, L.; Chapuis-Taillard, C.; de Vallière, S.; Hayoz, D.; Tarr, P. E.; Swiss HIV Cohort Study: High prevalence of peripheral arterial disease in HIV-infected persons. Clin. Infect. Dis., 2008, 46, 761-7. (Pubitemid 351321563)
54. Strategies for Management of Antiretroviral Therapy (SMART) Study Group.; El-Sadr, W. M.; Lundgren, J. D.; Neaton, J. D.; Gordin, F.; Abrams, D.; Arduino, R. C.; Babiker, A.; Burman, W.; Clumeck, N.; Cohen, C. J.; Cohn, D.; Cooper, D.; Darbyshire, J.; Emery, S.; Fätkenheuer, G.; Gazzard, B.; Grund, B.; Hoy, J.; Klingman, K.; Losso, M.; Markowitz, N.; Neuhaus, J.; Phillips, A.; Rappoport, C: CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med., 2006, 355, 2283-96. (Pubitemid 44837777)
55. Shimizu, Y.; Pierce, D. A.; Preston, D. L.; Mabuchi, K: Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat. Res., 1999, 152, 374-89. (Pubitemid 29463615)
56. Schultz-Hector, S.; Trott, K. R: Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int. J. Radiat. Oncol. Biol. Phys., 2007, 67, 10-8. (Pubitemid 44959506)
57. Kusunoki, Y.; Hayashi, T: Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int. J. Radiat. Biol., 2008, 84, 1-14. (Pubitemid 350208779)
58. Kasiske, B. L.; Guijarro, C.; Massy, Z. A.; Wiederkehr, M. R.; Ma, J. Z: Cardiovascular disease after renal transplantation. J. Am. Soc. Nephrol., 1996, 7, 158-165. (Pubitemid 26067103)
59. Kasiske, B. L.; Chakkera, H. A.; Roel, J: Explained and unexplained ischemic heart disease risk after renal transplantation. J. Am. Soc. Nephrol., 2000, 11, 1735-1743.
60. Libby, P: Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med., 2008, 121(Suppl 1), S21-31.
61. Karrar, A.; Sequeira, W.; Block, J. A: Coronary artery disease in systemic lupus erythematosus: A review of the literature. Semin. Arthritis. Rheum., 2001, 30, 436-43. (Pubitemid 32567500)
62. Horne, B. D.; Anderson, J. L.; John, J. M.; Weaver, A.; Bair, T. L.; Jensen, K. R.; Renlund, D. G.; Muhlestein, J. B.; Intermountain Heart Collaborative Study Group: Which white blood cell subtypes predict increased cardiovascular risk? J. Am. Coll. Cardiol., 2005, 45, 1638-43. (Pubitemid 40704499)
63. Núñez, J.; Sanchis, J.; Bodí, V.; Núñez, E.; Mainar, L.; Heatta, A. M.; Husser, O.; Miñana, G.; Merlos, P.; Darmofal, H.; Pellicer, M.; Llàcer, A: Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. Atherosclerosis, 2009, 206, 251-7.
64. Bodí, V.; Sanchis, J.; Núñez, J.; Rumiz, E.; Mainar, L.; López-Lereu, M. P.; Monmeneu, J. V.; Oltra, R.; Forteza, M. J.; Chorro, F. J.; Llácer, A: Post-Reperfusion lymphopenia and microvascular obstruction in ST-Segment elevation acute myocardial infarction. Rev. Esp. Cardiol., 2009, 62, 1109-17.
65. De Servi, S.; Mariani, M.; Mariani, G.; Mazzone, A: C-reactive protein increase in unstable coronary disease cause or effect? J. Am. Coll. Cardiol., 2005, 46, 1496-1502. (Pubitemid 41446185)
66. Kapadia, S. R: Cytokines and heart failure. Cardiol. Rev., 1999, 7, 196-206. (Pubitemid 29316247)
67. Torre-Amione, G: Immune activation in chronic heart failure. Am. J. Cardiol., 2005, 95, 3C-8C. (Pubitemid 40755512)
68. Huehnergarth, K. V.; Mozaffarian, D.; Sullivan, M. D.; Crane, B. A.; Wilkinson, C. W.; Lawler, R. L.; McDonald, G. B.; Fishbein, D. P.; Levy, W. C: Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am. J. Cardiol., 2005, 95, 1492-5. (Pubitemid 40824778)
69. Acanfora, D.; Gheorghiade, M.; Trojano, L.; Furgi, G.; Pasini, E.; Picone, C.; Papa, A.; Iannuzzi, G. L.; Bonow, R. O.; Rengo, F: Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure. Am. Heart. J., 2001, 142, 167-73. (Pubitemid 32595390)
70. Ommen, S. R.; Hammill, S. C.; Gibbons, R. J: The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. Pacing. Clin. Electrophysiol., 2002, 25, 1424-1248.
71. Comstock, K. L.; Krown, K. A.; Page, M. T.; Martin, D.; Ho, P.; Pedraza, M.; Castro, E. N.; Nakajima, N.; Glembotski, C. C.; Quintana, P. J.; Sabbadini, R. A: LPS-induced TNFalpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J. Mol. Cell. Cardiol., 1998, 30, 2761-2775. (Pubitemid 29017515)
72. Krabbe, K. S.; Bruunsgaard, H.; Qvist, J.; Fonsmark, L.; Moller, K.; Hansen, C. M.; Skinhoj, P.; Pedersen, B. K: Activated T lymphocytes disappear from circulation during endotoxemia in humans. Clin. Diagn. Lab. Immunol., 2002, 9, 731-735. (Pubitemid 34546022)
73. Castro, A.; Bemer, V.; Nobrega, A.; Coutinho, A.; Truffa-Bachi, P: Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur. J. Immunol., 1998, 28, 488-495. (Pubitemid 28101724)
74. Kaaya, G. P.; Maxie, M. G: The kinetics of haemopoietic differentiation assessed by in vitro bone marrow culture in endotoxin-treated and in anaemic calves. Res. Vet. Sci., 1980, 29, 63-67. (Pubitemid 11235499)
75. von Haehling, S.; Schefold, J. C.; Jankowska, E.; Doehner, W.; Springer, J.; Strohschein, K.; Genth-Zotz, S.; Volk, H. D.; Poole-Wilson, P.; Anker, S. D: Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. PLoS. One., 2009, 4, e6411.
76. Hotchkiss, R. S.; Chang, K. C.; Swanson, P. E.; Tinsley, K. W.; Hui, J. J.; Klender, P.; Xanthoudakis, S.; Roy, S.; Black, C.; Grimm, E.; Aspiotis, R.; Han, Y.; Nicholson, D. W.; Karl, I. E: Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol., 2000, 1, 496-501.
77. Oberholzer, C.; Oberholzer, A.; Bahjat, F. R.; Minter, R. M.; Tannahill, C. L.; Abouhamze, A.; LaFace, D.; Hutchins, B.; Clare-Salzler, M. J.; Moldawer, L. L: Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc. Natl. Acad. Sci. USA, 2001, 98, 11503-11508. (Pubitemid 32928758)
78. Hotchkiss, R. S.; Karl, I. E: The pathophysiology and treatment of sepsis. N. Engl. J. Med., 2003, 348, 138-50. (Pubitemid 36056721)
79. Wesche, D. E.; Lomas-Neira, J. L.; Perl, M.; Chung, C. S.; Ayala, A: Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol., 2005, 78, 325-37. (Pubitemid 41061305)